Atherotech elects Mason as VP of clinical operations

Kaitlyn Dmyterko | | Cardiovascular Business | Cardiac Imaging
In a move to expand its disease management and clinician services sectors, cardio-diagnostic developer Atherotech has appointed Jennifer E. Mason, RN, MS, as its vice president of clinical operations.

According to the Birmingham, Ala.-based company, responsibilities will include boosting the educational and outreach efforts for its line of cardiometabolic tests.

Prior to this position, Mason was employed as a clinician at the Berkeley HeartLab since 2001. With her new role, Mason will report to CEO Mike Mullen and work closely with Chief Medical Officer Michael Cobble, MD.

Kaitlyn Dmyterko

Related Content

Cardiologists work to standardize the diagnosis and management of acute myocarditis
New AI program delivers rapid, accurate echo video assessments
Cardiologists to highlight the many benefits of AI-powered CCTA evaluations
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Cleerly’s momentum continues as AI specialists raise $106M
Philips, Mayo Clinic using AI to improve cardiac MRI technology

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.